ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Philips, World Bank, and Ukraine Ministry of Health announce successful deployment of nationwide acute stroke care upgrade, helping thousands of patients

February 10, 2025

Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke  treatment network

Amsterdam, the Netherlands and Kyiv, Ukraine – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, in collaboration with the World Bank and Ukraine’s Ministry of Health (MOH), today announced a nationwide initiative to modernize stroke and cardiovascular care in Ukraine. The demand for stroke care in Ukraine is nearly doubling, exacerbated by war damage and displaced populations lacking access to timely care. This program – which is already well on its way – aims to address these immense challenges by creating an advanced network of locations for the diagnosis and treatment of stroke.

The joint initiative delivers advanced image-guided therapy systems optimized for acute stroke treatment to key regions, including Dnipro, Sumy, Kharkiv, Lviv, Zaporizhzha and Odesa. Philips is deploying 25 of its Azurion interventional suites to support minimally invasive stroke treatments. These systems support complex neurovascular procedures, such as thrombectomies*, which can reverse stroke effects. The systems integrate software tools and technologies to accelerate procedures and enhance care coordination. Together, these innovations streamline care pathways, reduce treatment delays and improve patient outcomes. Philips is working with its partner, AFS Medizintechnik, to roll out systems across the country. So far, 19 systems have been installed and are already helping Ukrainian physicians provide optimized care to their stroke patients.

“Every year, approximately 140,000 Ukrainians experience a stroke, with many facing disability or death due to delayed treatment,” said Carla Goulart Peron, Chief Medical Officer at Philips. “This collaboration ensures patients in underserved regions gain access to life-saving technologies.”

“This program is saving lives, reducing disability, and changing the futures of stroke patients,” said Dr. Dmytro Lebedynets, a neurologist at Feofaniya Clinical Hospital and consultant on stroke to the World Bank and the Ministry of Health of Ukraine. “With these advanced tools, we can deliver timely and precise life-saving care, even in emergencies. It’s a game-changer for our patients. Now all the regions of our country will be able to provide the full spectrum of care to stroke patients.”

Comprehensive training
The program also emphasizes comprehensive clinical training to ensure the new stroke network  is utilized to its full potential. As part of the initiative, physicians will undergo hands-on education and training in Poland. This approach guarantees the latest expertise in stroke treatment , enabling consistent high-quality care delivery across Ukraine.

Partnering with World Stroke Organization
Philips’ ongoing partnership with the World Stroke Organization, established in 2023, has been further expanded through its involvement in the WSO Advocacy Coalition, becoming part of a global network that actively works on healthcare policy, raises public awareness, and advocates for increased investment in stroke care infrastructure.

* A thrombectomy is a minimally invasive procedure where doctors use a small device called a catheter to remove a blood clot from a blood vessel, restoring normal blood flow and preventing damage to vital organs like the brain.

For further information, please contact:

Joost Maltha
Philips Global External Relations
Tel.: +31 6 10 55 8116
E-mail : joost.maltha@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  231.08
+4.11 (1.81%)
AAPL  269.20
+0.39 (0.15%)
AMD  260.88
+1.20 (0.46%)
BAC  52.59
-0.43 (-0.80%)
GOOG  268.65
-1.28 (-0.47%)
META  756.09
+5.27 (0.70%)
MSFT  542.97
+11.45 (2.15%)
NVDA  195.69
+4.20 (2.19%)
ORCL  283.19
+1.79 (0.64%)
TSLA  463.95
+11.53 (2.55%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.